Navigation Links
EmSense Announces Release of Revolutionary EmBand 24(TM)
Date:3/22/2010

SAN FRANCISCO, March 22 /PRNewswire/ -- EmSense Corporation, the company that created the first scalable electroencephalography (EEG) brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100322/AQ74210)

Using its Made for Purpose™ design, EmSense has employed several new proprietary technologies in the release of the new EmBand 24, including Sensor Fusion Processors™, Contact Clusters™ and Through the Hair EEG™.  The headset is designed specifically for market research and overcomes many limitations of using medical EEG for market research. 

"Now marketers can have more extensive, robust measurements without trading off consumer comfort, quantitative samples or ease of use," says Keith Winter, EmSense CEO.

EmSense proprietary sensors provide more targeted measurement with greater precision than medical sensors.  The Contact Cluster technology enables the ability to take individual anatomical differences into account and give maximum spatial resolution in targeted regions. New Through the Hair EEG sensors allow non-obtrusive measurement without the need for unpleasant, messy gels that require respondent clean-up. 

Using 24 EEG sensors, each measuring at 20,000 times per second, the headset collects 480,000 measurements per second.  In addition, the EmBand 24 provides an unparalleled signal-to-noise ratio in real-world, in-context conditions.  In keeping with the company's non-invasive design philosophy, the EmBand 24 headset does not require caps, gels or wires and calibrates in only one minute. 

"With the global availability of the EmBand 24," according to Chief Analytics Officer Elissa Moses, "the ability to objectively understand consumer engagement and emotional response will ultimately accelerate the success rate for ad campaigns, package restages and new product introductions."

The EmBand 24 affords clients increased measurement in the key decision center area of the frontal lobes, as well as added measurements such as visual attention from sensing additional areas of the brain.  The new EmBand 24 will primarily be utilized for in-context studies such as in-store shopper research and product innovation, while the current EmBand will continue to be used for advertising, concepts, media content, package testing, online marketing and web-site usability. 

About EmSense

EmSense is a leading-edge neuroscience company that applies advances in EEG and other neurometrics to provide clients with deep and reliable understanding of consumers' emotional and cognitive engagement with marketing stimuli. The company's quantitative metrics deliver breakthrough insights that facilitate the creation and optimization of advertising, concepts, packaging, media content, online marketing, web-site usability and both the live in-store and virtual store shopping experiences.  EmSense works directly with marketers and also partners with a variety of leading established market research firms including Dynamic Logic, Fifth Dimension, GfK North America, IRI, Millward Brown, Perception Research Services, Red Dot Square and TNS. EmSense provides expertise and advancements in emotion tracking, cognitive neuroscience, analytics, and market research through their proprietary EmBand and now EmBand 24, the first ever wireless, scalable, non-gel, non-invasive EEG neuroscience technology. The company is also the global leader in combining neurometrics with stationary and mobile eye tracking. EmSense Corporation is headquartered in San Francisco. To learn more about EmSense technology applications and neuroscience market research solutions, visit www.emsense.com.

SOURCE EmSense

Back to top

RELATED LINKS
http://www.emsense.com

'/>"/>

SOURCE EmSense
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):